Poster abstract: Treatment resistant cushing’s disease following standard and novel multi-modal therapy in the setting of a constitutional pathogenic MSH2 variant

Thomas Armstrong; Ben Loughrey; Fiona Eatock; John Lindsay

doi:10.1530/endoabs.104.P138

Poster abstract: Treatment resistant cushing’s disease following standard and novel multi-modal therapy in the setting of a constitutional pathogenic MSH2 variant

Thomas Armstrong, Ben Loughrey, Fiona Eatock, John Lindsay

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	P138
Number of pages	1
Journal	Endocrine Abstracts
DOIs	https://doi.org/10.1530/endoabs.104.P138
Publication status	Published - 2024
Event	Joint Irish-UK Endocrine Meeting 2024 - Belfast, United Kingdom Duration: 14 Oct 2024 → 15 Oct 2024

Access to Document

10.1530/endoabs.104.P138Licence: Unspecified

Cite this

@article{b6b4edee06c64b2b810f6aa49f1571c3,

title = "Poster abstract: Treatment resistant cushing{\textquoteright}s disease following standard and novel multi-modal therapy in the setting of a constitutional pathogenic MSH2 variant",

author = "Thomas Armstrong and Ben Loughrey and Fiona Eatock and John Lindsay",

year = "2024",

doi = "10.1530/endoabs.104.P138",

language = "English",

journal = "Endocrine Abstracts",

issn = "1470-3947",

note = "Joint Irish-UK Endocrine Meeting 2024<br/> ; Conference date: 14-10-2024 Through 15-10-2024",

}

TY - JOUR

T1 - Poster abstract: Treatment resistant cushing’s disease following standard and novel multi-modal therapy in the setting of a constitutional pathogenic MSH2 variant

AU - Armstrong, Thomas

AU - Loughrey, Ben

AU - Eatock, Fiona

AU - Lindsay, John

PY - 2024

Y1 - 2024

U2 - 10.1530/endoabs.104.P138

DO - 10.1530/endoabs.104.P138

M3 - Meeting abstract

SN - 1470-3947

JO - Endocrine Abstracts

JF - Endocrine Abstracts

M1 - P138

T2 - Joint Irish-UK Endocrine Meeting 2024<br/>

Y2 - 14 October 2024 through 15 October 2024

ER -